BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15124132)

  • 1. Update on the systemic treatment of malignant melanoma.
    Lawson DH
    Semin Oncol; 2004 Apr; 31(2 Suppl 4):33-7. PubMed ID: 15124132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant therapy for patients with high-risk malignant melanoma.
    McClay EF
    Semin Oncol; 2002 Aug; 29(4):389-99. PubMed ID: 12170442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant therapy of melanoma.
    Spitler LE
    Oncology (Williston Park); 2002 Jan; 16(1 Suppl 1):40-8. PubMed ID: 11829281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant therapy for malignant melanoma.
    Stoutenburg JP; Schrope B; Kaufman HL
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate- and high-risk melanoma.
    Agarwala SS
    Curr Treat Options Oncol; 2002 Jun; 3(3):205-17. PubMed ID: 12057066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EORTC melanoma group translational research program on prognostic factors and ultrastaging in association with the adjuvant therapy trials in stage II and stage III melanoma. European Organization for Research and Treatment of Cancer.
    Eggermont AM; Keilholz U; Testori A; Cook M; Lienard D; Ruiter DJ
    Ann Surg Oncol; 2001 Oct; 8(9 Suppl):38S-40S. PubMed ID: 11599896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
    Eggermont AM
    Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic therapy for cutaneous melanoma.
    Treisman J; Garlie N
    Clin Plast Surg; 2010 Jan; 37(1):127-46. PubMed ID: 19914464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma.
    Gershenwald JE
    Oncologist; 2001; 6(5):402-6. PubMed ID: 11675517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapeutics for the treatment of metastatic melanoma.
    Mansfield AS; Markovic SN
    Future Oncol; 2009 May; 5(4):543-57. PubMed ID: 19450181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the care of the patient with malignant melanoma.
    Reintgen D; Balch CM; Kirkwood J; Ross M
    Ann Surg; 1997 Jan; 225(1):1-14. PubMed ID: 8998115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (Neo)adjuvant systemic therapy for melanoma.
    van Zeijl MC; van den Eertwegh AJ; Haanen JB; Wouters MW
    Eur J Surg Oncol; 2017 Mar; 43(3):534-543. PubMed ID: 27453302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First International Symposium on Melanoma and Other Cutaneous Malignancies.
    Tarhini AA; Agarwala SS
    Expert Opin Biol Ther; 2004 Sep; 4(9):1541-6. PubMed ID: 15335320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What's new in the treatment of cutaneous melanoma?
    Olhoffer IH; Bolognia JL
    Semin Cutan Med Surg; 1998 Jun; 17(2):96-107. PubMed ID: 9669603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of melanoma with allogeneic melanoma lysates alone or with interferon-alfa.
    Mitchell MS; Darrah D; Stevenson L
    Cancer Invest; 2002; 20(5-6):759-68. PubMed ID: 12197233
    [No Abstract]   [Full Text] [Related]  

  • 16. Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapy.
    O'Day SJ; Boasberg PD; Piro L; Kristedja TS; Wang HJ; Martin M; Deck R; Ames P; Shinn K; Kim H; Fournier P; Gammon G
    Clin Cancer Res; 2002 Sep; 8(9):2775-81. PubMed ID: 12231516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma.
    Benson C; Gore ME
    Cancer Chemother Biol Response Modif; 2001; 19():629-38. PubMed ID: 11686036
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in management of melanoma.
    Hersey P
    Aust N Z J Med; 1999 Jun; 29(3):292-9. PubMed ID: 10868490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma and immunotherapy.
    Eggermont AM; Schadendorf D
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic adjuvant treatment of high-risk melanoma: the role of interferon alfa-2b and other immunotherapies.
    Kirkwood JM
    Eur J Cancer; 1998 Jul; 34 Suppl 3():S12-7. PubMed ID: 9849403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.